Literature DB >> 8833356

Changes in extent of ulcerative colitis: a study on the course and prognostic factors.

E Langholz1, P Munkholm, M Davidsen, O H Nielsen, V Binder.   

Abstract

BACKGROUND: The prognosis of patients with ulcerative colitis (UC) has previously been described with regard to mortality, cancer occurrence, and need for colectomy on the basis of an annual follow-up of a regional cohort of UC patients in Copenhagen County diagnosed in 1962-87. The objective of this study was to examine the prognosis with regard to spread of disease and to evaluate possible prognostic factors with regard to spread of disease and colectomy by multivariate regression analysis.
METHODS: An inception cohort of 1161 patients with UC was examined by actuarial analysis and by multivariate regression analysis of a subgroup of 467 patients diagnosed in 1979-87.
RESULTS: The probability for further progression of proctosigmoiditis, evaluated by sigmoidoscopy and radiology, was 53% after 25 years. The probability for regression was 76.8% for substantial colitis and 75.7% for pancolitis after 25 years. Multivariate regression analysis showed that the occurrence of the symptoms abdominal pain and diarrhoea was prognostically unfavourable with regard to the progression from proctosigmoiditis. Age influenced the regression probability in extensive disease. With regard to colectomy the following variables influenced the prognosis: fever, general condition, serum albumin, mucopus in stools, and diarrhoea at onset.
CONCLUSIONS: Disease extent in UC is not static but changes with time in approximately half of the patients. This finding should have implications for the follow-up. Ulcerative proctitis should be considered the same disease as UC and needs the same long-term follow-up.

Entities:  

Mesh:

Year:  1996        PMID: 8833356     DOI: 10.3109/00365529609004876

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  40 in total

1.  Current trends in inflammatory bowel disease: the natural history.

Authors:  Ebbe Langholz
Journal:  Therap Adv Gastroenterol       Date:  2010-03       Impact factor: 4.409

Review 2.  Surgical treatment of ulcerative colitis in the biologic therapy era.

Authors:  Alberto Biondi; Marco Zoccali; Stefano Costa; Albert Troci; Ettore Contessini-Avesani; Alessandro Fichera
Journal:  World J Gastroenterol       Date:  2012-04-28       Impact factor: 5.742

Review 3.  Top-down therapy for IBD: rationale and requisite evidence.

Authors:  Geert R D'Haens
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-02       Impact factor: 46.802

4.  Functional polymorphisms of the receptor for the advanced glycation end product promoter gene in inflammatory bowel disease: a case-control study.

Authors:  Rachele Ciccocioppo; Sara Bozzini; Elena Betti; Venerina Imbesi; Catherine Klersy; Lucia Sukovska Lakyova; Lukas Sukovsky; Jozef Benacka; Peter Kruzliak; Gino Roberto Corazza; Antonio Di Sabatino; Colomba Falcone
Journal:  Clin Exp Med       Date:  2019-06-07       Impact factor: 3.984

5.  Genetic markers in clinically well defined patients with ulcerative colitis (UC).

Authors:  G Bouma; J B Crusius; M A García-González; B U Meijer; H P Hellemans; R J Hakvoort; G M Schreuder; P J Kostense; S G Meuwissen; A S Peña
Journal:  Clin Exp Immunol       Date:  1999-02       Impact factor: 4.330

Review 6.  Impact of medical therapies on inflammatory bowel disease complication rate.

Authors:  Catherine Reenaers; Jacques Belaiche; Edouard Louis
Journal:  World J Gastroenterol       Date:  2012-08-07       Impact factor: 5.742

Review 7.  British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults.

Authors:  Christopher Andrew Lamb; Nicholas A Kennedy; Tim Raine; Philip Anthony Hendy; Philip J Smith; Jimmy K Limdi; Bu'Hussain Hayee; Miranda C E Lomer; Gareth C Parkes; Christian Selinger; Kevin J Barrett; R Justin Davies; Cathy Bennett; Stuart Gittens; Malcolm G Dunlop; Omar Faiz; Aileen Fraser; Vikki Garrick; Paul D Johnston; Miles Parkes; Jeremy Sanderson; Helen Terry; Daniel R Gaya; Tariq H Iqbal; Stuart A Taylor; Melissa Smith; Matthew Brookes; Richard Hansen; A Barney Hawthorne
Journal:  Gut       Date:  2019-09-27       Impact factor: 23.059

8.  Ulcerative proctitis.

Authors:  Charles B Whitlow
Journal:  Clin Colon Rectal Surg       Date:  2004-02

9.  Medical treatment of ulcerative colitis.

Authors:  Uma Mahadevan
Journal:  Clin Colon Rectal Surg       Date:  2004-02

Review 10.  Anti-TNF alpha in the treatment of ulcerative colitis: a valid approach for organ-sparing or an expensive option to delay surgery?

Authors:  Gianluca Rizzo; Daniela Pugliese; Alessandro Armuzzi; Claudio Coco
Journal:  World J Gastroenterol       Date:  2014-05-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.